373 related articles for article (PubMed ID: 32121271)
21. Detection of AR-V7 in Liquid Biopsies of Castrate Resistant Prostate Cancer Patients: A Comparison of AR-V7 Analysis in Circulating Tumor Cells, Circulating Tumor RNA and Exosomes.
Nimir M; Ma Y; Jeffreys SA; Opperman T; Young F; Khan T; Ding P; Chua W; Balakrishnar B; Cooper A; De Souza P; Becker TM
Cells; 2019 Jul; 8(7):. PubMed ID: 31288377
[TBL] [Abstract][Full Text] [Related]
22. Liquid biopsy in breast cancer: A comprehensive review.
Alimirzaie S; Bagherzadeh M; Akbari MR
Clin Genet; 2019 Jun; 95(6):643-660. PubMed ID: 30671931
[TBL] [Abstract][Full Text] [Related]
23. Liquid biopsy on chip: a paradigm shift towards the understanding of cancer metastasis.
Tadimety A; Syed A; Nie Y; Long CR; Kready KM; Zhang JX
Integr Biol (Camb); 2017 Jan; 9(1):22-49. PubMed ID: 27929582
[TBL] [Abstract][Full Text] [Related]
24. Liquid Biopsy: Current Status and Future Perspectives.
Mader S; Pantel K
Oncol Res Treat; 2017; 40(7-8):404-408. PubMed ID: 28693023
[TBL] [Abstract][Full Text] [Related]
25. The Present and Future of Liquid Biopsies in Non-Small Cell Lung Cancer: Combining Four Biosources for Diagnosis, Prognosis, Prediction, and Disease Monitoring.
Bracht JWP; Mayo-de-Las-Casas C; Berenguer J; Karachaliou N; Rosell R
Curr Oncol Rep; 2018 Jul; 20(9):70. PubMed ID: 30030656
[TBL] [Abstract][Full Text] [Related]
26. The Different Facets of Liquid Biopsy: A Kaleidoscopic View.
Eslami-S Z; Cortés-Hernández LE; Cayrefourcq L; Alix-Panabières C
Cold Spring Harb Perspect Med; 2020 Jun; 10(6):. PubMed ID: 31548226
[TBL] [Abstract][Full Text] [Related]
27. Liquid biopsy and PCR-free ultrasensitive detection systems in oncology (Review).
Finotti A; Allegretti M; Gasparello J; Giacomini P; Spandidos DA; Spoto G; Gambari R
Int J Oncol; 2018 Oct; 53(4):1395-1434. PubMed ID: 30085333
[TBL] [Abstract][Full Text] [Related]
28. Microfluidics for the Isolation and Detection of Circulating Tumor Cells.
Sierra-Agudelo J; Rodriguez-Trujillo R; Samitier J
Adv Exp Med Biol; 2022; 1379():389-412. PubMed ID: 35761001
[TBL] [Abstract][Full Text] [Related]
29. Cancer Liquid Biopsy Using Integrated Microfluidic Exosome Analysis Platforms.
Li G; Tang W; Yang F
Biotechnol J; 2020 May; 15(5):e1900225. PubMed ID: 32032977
[TBL] [Abstract][Full Text] [Related]
30. Recent Advances in Microfluidic Platforms Applied in Cancer Metastasis: Circulating Tumor Cells' (CTCs) Isolation and Tumor-On-A-Chip.
Lin Z; Luo G; Du W; Kong T; Liu C; Liu Z
Small; 2020 Mar; 16(9):e1903899. PubMed ID: 31747120
[TBL] [Abstract][Full Text] [Related]
31. [Recent advances in isolation and detection of circulating tumor cells with a microfluidic system].
Cao R; Zhang M; Yu H; Qin J
Se Pu; 2022 Mar; 40(3):213-223. PubMed ID: 35243831
[TBL] [Abstract][Full Text] [Related]
32. Liquid biopsy in ovarian cancer using circulating tumor DNA and cells: Ready for prime time?
Asante DB; Calapre L; Ziman M; Meniawy TM; Gray ES
Cancer Lett; 2020 Jan; 468():59-71. PubMed ID: 31610267
[TBL] [Abstract][Full Text] [Related]
33. The potential of liquid biopsies in gastrointestinal cancer.
Wu C; Zhang J; Li H; Xu W; Zhang X
Clin Biochem; 2020 Oct; 84():1-12. PubMed ID: 32540214
[TBL] [Abstract][Full Text] [Related]
34. The Use of Microfluidic Technology for Cancer Applications and Liquid Biopsy.
Kulasinghe A; Wu H; Punyadeera C; Warkiani ME
Micromachines (Basel); 2018 Aug; 9(8):. PubMed ID: 30424330
[TBL] [Abstract][Full Text] [Related]
35. Challenges and achievements of liquid biopsy technologies employed in early breast cancer.
Alba-Bernal A; Lavado-Valenzuela R; Domínguez-Recio ME; Jiménez-Rodriguez B; Queipo-Ortuño MI; Alba E; Comino-Méndez I
EBioMedicine; 2020 Dec; 62():103100. PubMed ID: 33161226
[TBL] [Abstract][Full Text] [Related]
36. Fast and Label-Free Isolation of Circulating Tumor Cells from Blood: From a Research Microfluidic Platform to an Automated Fluidic Instrument, VTX-1 Liquid Biopsy System.
Lemaire CA; Liu SZ; Wilkerson CL; Ramani VC; Barzanian NA; Huang KW; Che J; Chiu MW; Vuppalapaty M; Dimmick AM; Carlo DD; Kochersperger ML; Crouse SC; Jeffrey SS; Englert RF; Hengstler S; Renier C; Sollier-Christen E
SLAS Technol; 2018 Feb; 23(1):16-29. PubMed ID: 29355087
[TBL] [Abstract][Full Text] [Related]
37. Precisely Enumerating Circulating Tumor Cells Utilizing a Multi-Functional Microfluidic Chip and Unique Image Interpretation Algorithm.
Zhou M; Zheng H; Wang Z; Li R; Liu X; Zhang W; Wang Z; Li H; Wei Z; Hu Z
Theranostics; 2017; 7(19):4710-4721. PubMed ID: 29187898
[TBL] [Abstract][Full Text] [Related]
38. Rethinking liquid biopsy: Microfluidic assays for mobile tumor cells in human body fluids.
Neoh KH; Hassan AA; Chen A; Sun Y; Liu P; Xu KF; Wong AST; Han RPS
Biomaterials; 2018 Jan; 150():112-124. PubMed ID: 29035737
[TBL] [Abstract][Full Text] [Related]
39. Application of liquid biopsy in precision medicine: opportunities and challenges.
Wang J; Chang S; Li G; Sun Y
Front Med; 2017 Dec; 11(4):522-527. PubMed ID: 28744793
[TBL] [Abstract][Full Text] [Related]
40. Diagnosis and treatment monitoring in breast cancer: how liquid biopsy can support patient management.
Cucchiara F; Scarpitta R; Crucitta S; Scatena C; Arici R; Naccarato AG; Fogli S; Danesi R; Del Re M
Pharmacogenomics; 2022 Jan; 23(2):119-134. PubMed ID: 35006002
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
